News
A
139.06
+1.24%
1.70
Buy Rating Affirmed with Increased Price Target for Agilent Amidst Stabilizing Chinese Market and Strong Q1 Performance
TipRanks · 2d ago
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 2.3% on an annualized basis. The company has an average annual return of 12.77%. A has a market capitalization of $40.28 billion. If an investor bought $100 of A 10 years ago, it would be worth $332.64 today.
Benzinga · 3d ago
Agilent Technologies Reaches Analyst Target Price
NASDAQ · 3d ago
Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving Markets Wednesday?
Stocks dipped modestly on Wednesday following a marginal downward revision in the U.S. Economic growth rate for the last quarter of the year. The real estate sector emerged as a notable exception, outperforming other sectors. Bitcoin gained over 7% for the day to break above $61,000. UnitedHealth Group was the major laggard among mega-cap stocks.
Benzinga · 4d ago
Citigroup Maintains Neutral on Agilent Technologies, Raises Price Target to $145
Benzinga · 4d ago
UBS Maintains Neutral on Agilent Technologies, Raises Price Target to $155
Benzinga · 4d ago
Assessing Agilent Technologies: Insights From 6 Financial Analysts
6 analysts have published ratings on Agilent Technologies (NYSE:A) in the last three months. The company has an average price target of $136.67. The 12-month price targets assessed by analysts reveal insights into the company's financial performance. The firm was spun out of Hewlett-Packard in 1999.
Benzinga · 4d ago
Evercore ISI Group Maintains In-Line on Agilent Technologies, Lowers Price Target to $132
Benzinga · 4d ago
Stocks Fall Back Ahead of Thursday’s PCE Deflator Report
NASDAQ · 4d ago
Barclays Maintains Underweight on Agilent Technologies, Raises Price Target to $125
Benzinga · 4d ago
More
Webull provides a variety of real-time A stock news. You can receive the latest news about Agilent Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About A
Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers services portfolio, which includes repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting and various other custom services to support the laboratory operations.